SCHEMBL1990394

SCHEMBL1990394

CCN(CC)CCCS(=O)(=O)N[C@H](CCc1ccccc1)c1nc(Cc2ccccc2Br)no1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.49
CCR4 P51679 2/20 0.35
SRC P12931 3/20 0.34
ZAP70 P43403 3/20 0.34
SCN1A P35498 2/20 0.34
SCN2A Q99250 2/20 0.34
SCN3A Q9NY46 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MEN1 O00255 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33
TSHR P16473 1/20 0.33
GAA P10253 1/20 0.32
HTR1A P08908 2/20 0.32
CHRM2 P08172 1/20 0.32
ADRA2A P08913 1/20 0.32
CHRM1 P11229 1/20 0.32
DRD1 P21728 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1989861 0.91 GHSR (0.50) GHSRCCR4SRCZAP70SCN1A
SCHEMBL1991288 0.90 GHSR (0.49) GHSRCCR4SRCZAP70SCN1A
SCHEMBL1991024 0.90 GHSR (0.49) GHSRCCR4SRCZAP70SCN1A
SCHEMBL1990054 0.89 GHSR (0.54) GHSRCCR4SRCZAP70SCN1A
SCHEMBL1989518 0.88 GHSR (0.48) GHSRCCR4SRCZAP70SCN1A
SCHEMBL1994348 0.88 GHSR (0.54) GHSRCCR4SRCZAP70SCN1A
SCHEMBL2007913 0.87 GHSR (0.50) GHSRCCR4SRCZAP70SCN1A
SCHEMBL1993678 0.85 GHSR (0.48) GHSRCCR4SRCZAP70L3MBTL1
SCHEMBL1991756 0.85 GHSR (0.62) GHSRCCR4SRCZAP70L3MBTL1
SCHEMBL2004928 0.85 GHSR (0.51) GHSRCCR4SRCZAP70SCN1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152232-A1 SULFONAMIDE COMPOUNDS AND USES THEREOF SAUNDERS JEFFREY O 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152232-A1 SULFONAMIDE COMPOUNDS AND USES THEREOF GHSR, GHRHR, SSTR2 GHSR 1/4885CCR4 4184/4885SRC 2407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.